|
SNAPIN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.135800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.660100E-03 |
| Normal-vs-Stage2 |
2.150000E-01 |
| Normal-vs-Stage3 |
4.227800E-02 |
| Normal-vs-Stage4 |
3.958000E-02 |
| Stage1-vs-Stage2 |
7.312800E-01 |
| Stage1-vs-Stage3 |
9.943200E-01 |
| Stage1-vs-Stage4 |
5.763200E-01 |
| Stage2-vs-Stage3 |
7.740000E-01 |
| Stage2-vs-Stage4 |
5.153800E-01 |
| Stage3-vs-Stage4 |
6.336200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.180500E-02 |
| Normal-vs-AfricanAmerican |
2.271900E-02 |
| Normal-vs-Asian |
4.036000E-04 |
| Caucasian-vs-AfricanAmerican |
2.183000E-01 |
| Caucasian-vs-Asian |
2.430200E-02 |
| AfricanAmerican-vs-Asian |
6.930200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.148000E-02 |
| Normal-vs-Female |
2.724100E-03 |
| Male-vs-Female |
4.109200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.966120E-02 |
| Normal-vs-Age(41-60Yrs) |
1.066210E-02 |
| Normal-vs-Age(61-80Yrs) |
3.289600E-02 |
| Normal-vs-Age(81-100Yrs) |
8.203000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.678000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.500400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.073600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.328400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.960600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.033400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.601960E-01 |
| Classical-VS-Follicular |
1.285760E-02 |
| Classical-VS-Other |
4.057000E-01 |
| Classical-VS-Normal |
1.391080E-04 |
| Tall-VS-Follicular |
6.103800E-01 |
| Tall-VS-Other |
9.071400E-01 |
| Tall-VS-Normal |
3.937800E-01 |
| Follicular-VS-Other |
8.912400E-01 |
| Follicular-VS-Normal |
7.664600E-01 |
| Other-VS-Normal |
6.679200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.743800E-02 |
| Normal-vs-N1 |
3.134200E-01 |
| N0-vs-N1 |
9.135600E-01 |
|
|
